Fundraising Fox
/Companies
Sign in

Lodestone Biomedical

Lebanon, US · Founded 2015 · Delaware corporation

Find your way into Lodestone Biomedical

401 people in our graph share verified history with the Lodestone Biomedical team — schools, employers, funds. One of them is your warm intro.

Erica Sununlockedknows Solomon Diamond · together at Dartmouth College (overlapped)
×11knows the team · via Dartmouth College

Lodestone Biomedical develops biosensing and monitoring tools for the tumor microenvironment in preclinical cancer research models, enabling detection of immune response during early-stage drug discovery. Its research-use-only products and services serve drug development researchers conducting preclinical studies.

BiotechDeep TechHealthtech

Founders & leadership

Lodestone Biomedical was founded in 2015 by Solomon Diamond.

SD
Solomon DiamondCo-FounderSolomon Diamond is an associate professor of engineering at Dartmouth, where he teaches capstone design and computer-aided design courses. His research background includes functional neuroimaging and in vivo biosensing of immune response in the tumor microenvironment using magnetic nanoparticles, which he is translating into practice through Lodestone Biomedical.
LV
Lidia ValdesNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$1.2M disclosed across 4 rounds · 2017–2025

▶$75KraisedJul 2025 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Solomon DiamondExecutive Officer, Director
Offering amount
$2M
Amount sold
$75K
First sale
Jun 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$450KraisedDec 2021 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Solomon DiamondExecutive Officer, Director
Offering amount
$1M
Amount sold
$450K
First sale
Dec 2021
Incorporated
Limited Liability Company, New Hampshire
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$110KraisedApr 2020 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Solomon DiamondExecutive Officer, Director
Offering amount
$400K
Amount sold
$110K
Minimum investment
$5K
First sale
Mar 2020
Incorporated
Limited Liability Company, New Hampshire, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$550KraisedJul 2017 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Solomon DiamondExecutive Officer, Director
  • Lidia ValdesExecutive Officer, Director
Offering amount
$600K
Amount sold
$550K
Minimum investment
$5K
Proceeds to insiders
$100K
First sale
Jul 2017
Incorporated
Limited Liability Company, New Hampshire, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$2M
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$400K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Lodestone Biomedical do?
Lodestone Biomedical develops biosensing and monitoring tools for the tumor microenvironment in preclinical cancer research models, enabling detection of immune response during early-stage drug discovery. Its research-use-only products and services serve drug development researchers conducting preclinical studies.
Who founded Lodestone Biomedical?
Lodestone Biomedical was founded by Solomon Diamond in 2015.
How much funding has Lodestone Biomedical raised?
Lodestone Biomedical has disclosed $1.2M raised across 4 rounds.
Where is Lodestone Biomedical headquartered?
Lodestone Biomedical is headquartered in Lebanon, US.